NewGenIvf Group Total Risk Alpha
| NIVF Stock | | | 1.59 -0.04 -2.45% |
Historical market data for NewGenIvf Group Limited forms the basis of the Total Risk Alpha indicator shown here. Coverage may vary depending on data availability and normalization methods. NewGenIvf Group has a market cap of 926.48 K, operating margin of -1.96%, ROE of 1.61%. See
Correlation Analysis for additional portfolio context. This captures an allocation to NewGenIvf Group Limited. The allocation framework shapes how individual positions are weighted. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in manufacturing.
NewGenIvf Group Limited has current Total Risk Alpha of
-1.32. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | -1.32 | |
| ER[a] | = | Expected return on investing in NewGenIvf Group |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on NewGenIvf Group |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
NewGenIvf Group Limited is rated
below average in total risk alpha across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set .
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare NewGenIvf Group to Peers
Other Technical Indicators